Clinical Trials

Showing trials with last updates posted in 2024.

NCT04432857 | ACTIVE_NOT_RECRUITING | PHASE1
63 participants

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2024-06-27
Start Date:
2020-08-20
Completion:
2024-05-31
Conditions
  • Triple-negative Breast Cancer
  • NSCLC, Squamous or Non-Squamous
  • Urothelial Carcinoma of the Bladder
  • Microsatellite Stable (MSS) Colorectal Cancer (CRC)
  • Cervical Cancer
Interventions
  • DRUG
No Results Yet
NCT04209114 | COMPLETED | PHASE3
114 participants

A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2024-06-27
Start Date:
2020-02-05
Completion:
2023-06-07
Conditions
  • Bladder Cancer
  • Bladder Tumor
  • Muscle-Invasive Bladder Cancer
Interventions
  • BIOLOGICAL
  • PROCEDURE
NCT04148716 | COMPLETED
11 participants

microRNAs in Systemic Scleroderma

Study Type:
OBSERVATIONAL
Last Updated:
2024-06-27
Start Date:
2021-01-11
Completion:
2022-12-22
Conditions
  • Scleroderma, Systemic
Interventions
  • PROCEDURE
No Results Yet
NCT04004767 | COMPLETED
220 participants

TRC-PAD Program: In-Clinic Trial-Ready Cohort

Study Type:
OBSERVATIONAL
Last Updated:
2024-06-27
Start Date:
2019-06-04
Completion:
2024-04-01
Conditions
  • Preclinical Alzheimer's Disease
  • Prodromal Alzheimer's Disease
  • Alzheimer Disease
  • Dementia
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page